Cargando…

Systemic therapy in metastatic renal cell carcinoma

PURPOSE: Current systemic treatment of targeted therapies, namely the vascular endothelial growth factor-antibody (VEGF-AB), VEGF receptor tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitors, have improved progression-free survival and replaced non-specific immunother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedke, Jens, Gauler, Thomas, Grünwald, Viktor, Hegele, Axel, Herrmann, Edwin, Hinz, Stefan, Janssen, Jan, Schmitz, Stephan, Schostak, Martin, Tesch, Hans, Zastrow, Stefan, Miller, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272893/ https://www.ncbi.nlm.nih.gov/pubmed/27277600 http://dx.doi.org/10.1007/s00345-016-1868-5

Ejemplares similares

Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)
por: Ivanyi, Philipp, et al.
Publicado: (2020)

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma
por: Busch, Jonas, et al.
Publicado: (2011)

Real world data on IO-based therapy for metastatic renal cell carcinoma
por: Stühler, Viktoria, et al.
Publicado: (2022)

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
por: Pogorzelski, Michael, et al.
Publicado: (2021)

Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment
por: Grünwald, Viktor, et al.
Publicado: (2012)

Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab
por: Stühler, Viktoria, et al.
Publicado: (2022)

Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019)

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape
por: Doehn, Christian, et al.
Publicado: (2022)

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer
por: Hegemann, Miriam, et al.
Publicado: (2019)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
por: Stühler, Viktoria, et al.
Publicado: (2022)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2018)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Novel implications in the treatment of hepatocellular carcinoma
por: Best, Jan, et al.
Publicado: (2017)

A Rare Case of Synchronous Renal Cell Carcinoma of the Bladder Presenting With Gross Hematuria
por: Kruck, Stephan, et al.
Publicado: (2013)

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis
por: Eggers, Hendrik, et al.
Publicado: (2017)

Renal failure as a complication of defunctioning ileostomy: more complexity to a complex decision-making process
por: Lederhuber, Hans
Publicado: (2023)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy
por: Bedke, Jens, et al.
Publicado: (2013)

Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma
por: Dornbusch, Juana, et al.
Publicado: (2013)

Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2015)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

UCP-3 uncoupling protein confers hypoxia resistance to renal epithelial cells and is upregulated in renal cell carcinoma
por: Braun, Norbert, et al.
Publicado: (2015)

Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
por: Kitamura, Takanori, et al.
Publicado: (2015)

Isolated native renal hydatidosis in a renal transplant patient: The case for an aggressive approach
por: Mubarak, Muhammed
Publicado: (2018)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

Historical milestones in renal pathology
por: Weening, Jan J., et al.
Publicado: (2012)

Epidemiology and screening for renal cancer
por: Rossi, Sabrina H., et al.
Publicado: (2018)

Renal blood flow and oxygenation
por: Edwards, Aurelie, et al.
Publicado: (2022)

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
por: Markowski, Mark C, et al.
Publicado: (2015)

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study
por: Bergmann, Lothar, et al.
Publicado: (2015)

Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches
por: Posdzich, Philip, et al.
Publicado: (2023)

Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer
por: Kollermann, Jens, et al.
Publicado: (2006)

Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
por: Fischer, Christine, et al.
Publicado: (2020)

Renal denervation as an option for the management of hypertension
por: Santiapillai, Georgina Radhini, et al.
Publicado: (2014)

Precision medicine in renal stone-formers
por: Hill, Fay, et al.
Publicado: (2018)

Anticoagulation during Renal Replacement Therapy
por: Singh, Simran
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ornqb65pm3fpa8u7ujbdljf80n